Evidence map›Paper›PMID 32477333›Full record

ArticleFrontiers in immunology2020

Inhibitory Effects of Dietary

Susana Figueroa-Lozano, Rivca L Valk-Weeber, Renate Akkerman, Wayel Abdulahad, Sander S van Leeuwen, Lubbert Dijkhuizen, Paul de Vos

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. The host targeting effect of chloroquine in malaria.Current opinion in immunology · 2020
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Susana Figueroa-LozanoImmunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Rivca L Valk-WeeberMicrobial Physiology, Groningen Biomolecular Sciences and Biotechnology Institute (GBB), Groningen, Netherlands.
Renate AkkermanImmunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Wayel AbdulahadImmunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Sander S van LeeuwenMicrobial Physiology, Groningen Biomolecular Sciences and Biotechnology Institute (GBB), Groningen, Netherlands.
Lubbert DijkhuizenMicrobial Physiology, Groningen Biomolecular Sciences and Biotechnology Institute (GBB), Groningen, Netherlands.
Paul de VosImmunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
University of Groningen · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toll-like receptor 8 (TLR-8) plays a role in the pathogenesis of autoimmune disorders and associated gastrointestinal symptoms that reduce quality of life of patients. Dietary interventions are becoming more accepted as mean to manage onset, progression, and treatment of a broad spectrum of inflammatory conditions. In this study, we assessed the impact of

Indexed as

AnimalsBlood DonorsCattleChloroquineDendritic CellsHEK293 CellsHumansInterleukin-6LactoferrinMonocytesPolysaccharidesReal-Time Polymerase Chain ReactionRNA, MessengerSignal TransductionToll-Like Receptor 8ChloroquineIL6 protein, humanInterleukin-6LactoferrinPolysaccharidesRNA, MessengerTLR8 protein, humanToll-Like Receptor 8autoimmune disordersbovine lactoferrinimmunomodulationinhibitionN-glycosylationTLR-8

Identifiers

PMID32477333
PMCPMC7235371
OpenAlexW3025041756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.